Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
23/09/2026 02:28
BRIEF-Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive Sept 23 (Reuters) - Firebrick Pharma Ltd FRE.AX:
FIREBRICK PHARMA LTD-FIREBRICK RECEIVES $293,000 RESEARCH AND DEVELOPMENT TAX INCENTIVE
FIREBRICK PHARMA LTD - ALL FIGURES IN AUD
Further company coverage: FRE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Firebrick Pharma
See all newsAustralia's Firebrick Pharma jumps on plan to launch Nasodine products in US retail market
Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
Brief: Firebrick Pharma Says Nasodine Composition Patent Granted In New Zealand
Brief: Firebrick Pharma Says Nasodine Patent Accepted In Canada
Brief: Firebrick Pharma Secures A$1.5 Million Via Placement